CBT-004

N/A

Report date: 2024/03/04 14:33:05

Base Information

Drug NameCBT-004

Drug Alias NameCBT-004

ClassificationSmall molecules

Mechanisms of ActionVascular endothelial growth factor receptor antagonistsPlatelet-derived growth factor receptor inhibitorsProtein kinases inhibitors

TargetsVascular endothelial growth factor receptorPlatelet-derived growth factor receptorProtein kinases

Therapy Area/IndicationsPinguecula

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesCloudbreak Biomedical Technology (Guangzhou) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesCloudbreak Therapeutics Llc

Inactive CompaniesN/A

Active IndicationsPinguecula

Inactive IndicationsN/A

Other Information

ATC CodeN/A